Prof. Dr. med. Detlef Haase

Name Card

Main Affiliation
 
Staff Status
unigoe
 

1-26 of 26
 
The bibliographical data in your publication list are complete
You can correct existing data in the blue highlighted fields.To do this, please click on the coloured field. It is not possible to delete data here.
Fields that are not marked in colour (e. g. the authors) can be edited using the input form. To do so, click on the in front of the respective publication.
The bibliographic data in your publication list may be incomplete. You can
  • add any missing data in the fields marked in red or
  • correct existing data in the blue highlighted fields.
To do this, please click on the coloured field. It is not possible to delete data here.
Fields that are not marked in colour (e. g. the authors) can be edited using the input form. To do so, click on the in front of the respective publication.
Check/Uncheck all
  • 2022 | Journal Article | 
    ​ ​Outcomes of second allogeneic stem cell transplantation and anti‐relapse strategies in patients with relapsed/refractory acute myeloid leukemia: A unicentric retrospective analysis​
    Shumilov, E.; Hasenkamp, J. ; Maulhardt, M.; Mazzeo, P.; Schmidt, N.; Boyadzhiev, H. & Jung, W.  et al.​ (2022) 
    Hematological Oncology, 40(4) pp. 763​-776​.​ DOI: https://doi.org/10.1002/hon.2995 
    ​Details  DOI 
  • 2020 | Journal Article
    ​ ​Acute Myeloid Leukemia and Myelodysplastic Syndromes with TP53 Aberrations — A Distinct Stem Cell Disorder​
    Sill, H.; Zebisch, A. & Haase, D. ​ (2020) 
    Clinical Cancer Research, 26(20) pp. 5304​-5309​.​ DOI: https://doi.org/10.1158/1078-0432.CCR-20-2272 
    ​Details  DOI 
  • 2020 | Journal Article
    ​ ​SF3B1-mutant MDS as a distinct disease subtype: a proposal from the International Working Group for the Prognosis of MDS​
    Malcovati, L.; Stevenson, K.; Papaemmanuil, E.; Neuberg, D.; Bejar, R.; Boultwood, J. & Bowen, D. T. et al.​ (2020) 
    Blood, 136(2) pp. 157​-170​.​ DOI: https://doi.org/10.1182/blood.2020004850 
    ​Details  DOI 
  • 2020 | Journal Article
    ​ ​Impact of somatic mutations in myelodysplastic patients with isolated partial or total loss of chromosome 7​
    Crisà, E.; Kulasekararaj, A. G.; Adema, V.; Such, E.; Schanz, J. ; Haase, D.   & Shirneshan, K.  et al.​ (2020) 
    Leukemia, 34(9) pp. 2441​-2450​.​ DOI: https://doi.org/10.1038/s41375-020-0728-x 
    ​Details  DOI 
  • 2019 | Journal Article
    ​ ​Proposed diagnostic criteria for classical chronic myelomonocytic leukemia (CMML), CMML variants and pre-CMML conditions​
    Valent, P.; Orazi, A.; Savona, M. R.; Patnaik, M. M.; Onida, F.; van de Loosdrecht, A. A. & Haase, D.  et al.​ (2019) 
    Haematologica, 104(10) pp. 1935​-1949​.​ DOI: https://doi.org/10.3324/haematol.2019.222059 
    ​Details  DOI 
  • 2019 | Journal Article | 
    ​ ​TP53 mutation status divides myelodysplastic syndromes with complex karyotypes into distinct prognostic subgroups​
    Haase, D. ; Stevenson, K. E.; Neuberg, D.; Maciejewski, J. P.; Nazha, A.; Sekeres, M. A. & Ebert, B. L. et al.​ (2019) 
    Leukemia, 33(7) pp. 1747​-1758​.​ DOI: https://doi.org/10.1038/s41375-018-0351-2 
    ​Details  DOI 
  • 2019 | Journal Article
    ​ ​Comprehensive analysis of isolated der(1;7)(q10;p10) in a large international homogenous cohort of patients with myelodysplastic syndromes​
    Ganster, C.; Müller‐Thomas, C.; Haferlach, C.; Strupp, C.; Ogata, K.; Germing, U. & Hildebrandt, B. et al.​ (2019) 
    Genes, Chromosomes and Cancer, 58(10) pp. 689​-697​.​ DOI: https://doi.org/10.1002/gcc.22760 
    ​Details  DOI 
  • 2019 | Journal Article
    ​ ​Digital droplet PCR‐based chimerism analysis for monitoring of hematopoietic engraftment after allogeneic stem cell transplantation​
    Mika, T.; Baraniskin, A.; Ladigan, S.; Wulf, G. ; Dierks, S.; Haase, D.   & Schork, K. et al.​ (2019) 
    International Journal of Laboratory Hematology, 41(5) pp. 615​-621​.​ DOI: https://doi.org/10.1111/ijlh.13073 
    ​Details  DOI 
  • 2018 | Journal Article
    ​ ​Clonal architecture in patients with myelodysplastic syndromes and double or minor complex abnormalities: Detailed analysis of clonal composition, involved abnormalities, and prognostic significance​
    Schanz, J. ; Solé, F.; Mallo, M.; Luño, E.; Cervera, J.; Granada, I. & Hildebrandt, B. et al.​ (2018) 
    Genes, Chromosomes and Cancer, 57(11) pp. 547​-556​.​ DOI: https://doi.org/10.1002/gcc.22667 
    ​Details  DOI 
  • 2018 | Journal Article
    ​ ​Prognostic impact of a suboptimal number of analyzed metaphases in normal karyotype lower-risk MDS​
    de Swart, L.; Smith, A.; Haase, D. ; Fenaux, P.; Symeonidis, A.; Cermak, J. & Sanz, G. et al.​ (2018) 
    Leukemia Research, 67 pp. 21​-26​.​ DOI: https://doi.org/10.1016/j.leukres.2018.01.022 
    ​Details  DOI 
  • 2018 | Journal Article
    ​ ​The IPSS-R has prognostic impact in untreated patients with MDS del(5q)​
    Kaivers, J.; Lauseker, M.; Hildebrandt, B. ; Fenaux, P.; Pfeilstöcker, M.; Valent, P. & Platzbecker, U. et al.​ (2018) 
    Leukemia Research, 72 pp. 27​-33​.​ DOI: https://doi.org/10.1016/j.leukres.2018.07.019 
    ​Details  DOI 
  • 2018 | Journal Article
    ​ ​MDS1 and EVI1 complex locus (MECOM): a novel candidate gene for hereditary hematological malignancies​
    Ripperger, T.; Hofmann, W.; Koch, J. C. ; Shirneshan, K. ; Haase, D. ; Wulf, G.   & Issing, P. R. et al.​ (2018) 
    Haematologica, 103(2) pp. e55​-e58​.​ DOI: https://doi.org/10.3324/haematol.2017.178723 
    ​Details  DOI 
  • 2018 | Journal Article
    ​ ​The Role of PPM1D Mutations in Lenalidomide Resistance and Progression in Patients with MDS and Deletion of Chromosome 5q​
    Panagiota, V.; Meggendorfer, M.; Kubasch, A. S.; Gabdoulline, R.; Krönke, J.; Shahswar, R. & Mies, A. et al.​ (2018) 
    Blood, 132(Supplement 1) pp. 4360​-4360​.​ DOI: https://doi.org/10.1182/blood-2018-99-114026 
    ​Details  DOI 
  • 2018 | Journal Article
    ​ ​Real Life Dates of Chronic Lymphocytic Leukemia (CLL) in Germany. Interim Analysis of 234 Consecutively New Diagnosed Patients in a German Epidemiological-Clinical Register​
    Kämpfe, D.; Stein, H.; Bob, R.; Böttcher, S.; Brenn, J.; Knopp, A. & Haverkamp, T. et al.​ (2018) 
    Blood, 132(Supplement 1) pp. 2264​-2264​.​ DOI: https://doi.org/10.1182/blood-2018-99-110618 
    ​Details  DOI 
  • 2018 | Journal Article
    ​ ​Prospective Multicenter Phase 3 Study Comparing 5-Azacytidine (5-Aza) Induction Followed By Allogeneic Stem Cell Transplantation Versus Continuous 5-Aza According to Donor Availability in Elderly MDS Patients (55-70 years) (VidazaAllo Study)​
    Kroeger, N.; Sockel, K.; Wolschke, C.; Bethge, W.; Schlenk, R. F.; Wolf‎, D. & Stadler, M. et al.​ (2018) 
    Blood, 132(Supplement 1) pp. 208​-208​.​ DOI: https://doi.org/10.1182/blood-2018-99-115932 
    ​Details  DOI 
  • 2018 | Journal Article
    ​ ​Molecular Profile and Cytomorphological Manifestation of Isolated Y Loss in Myelodysplastic Syndromes​
    Ganster, C.; Harder, L.; Bacher, U. ; Shirneshan, K. ; Dierks, S.; Martin, R. & Rittscher, K. et al.​ (2018) 
    Blood, 132(Supplement 1) pp. 4358​-4358​.​ DOI: https://doi.org/10.1182/blood-2018-99-114216 
    ​Details  DOI 
  • 2018 | Journal Article
    ​ ​Therapy-Related MDS Can be Separated into Different Risk-Groups According to Tools for Classification and Prognostication of Primary MDS​
    Kuendgen, A.; Nomdedeu, M.; Tuechler, H.; Garcia-Manero, G.; Komrokji, R. S.; Sekeres, M. A. & Della Porta, M. G. et al.​ (2018) 
    Blood, 132(Supplement 1) pp. 3103​-3103​.​ DOI: https://doi.org/10.1182/blood-2018-99-118215 
    ​Details  DOI 
  • 2018 | Journal Article | 
    ​ ​Detailed analysis of clonal evolution and cytogenetic evolution patterns in patients with myelodysplastic syndromes (MDS) and related myeloid disorders​
    Schanz, J. ; Cevik, N.; Fonatsch, C.; Braulke, F. ; Shirneshan, K. ; Bacher, U.   & Haase, D. ​ (2018) 
    Blood Cancer Journal, 8(3).​ DOI: https://doi.org/10.1038/s41408-018-0061-z 
    ​Details  DOI 
  • 2018 | Journal Article
    ​ ​Targeted deep sequencing of CD34+ cells from peripheral blood can reproduce bone marrow molecular profile in myelodysplastic syndromes​
    Martin, R.; Acha, P.; Ganster, C.; Palomo, L.; Dierks, S.; Fuster‐Tormo, F. & Mallo, M. et al.​ (2018) 
    American Journal of Hematology, 93(6).​ DOI: https://doi.org/10.1002/ajh.25089 
    ​Details  DOI 
  • 2017 | Journal Article
    ​ ​Peripheral blood cytogenetics allows treatment monitoring and early identification of treatment failure to lenalidomide in MDS patients: results of the LE-MON-5 trial​
    Braulke, F. ; Schulz, X. ; Germing, U.; Schuler, E.; Platzbecker, U.; Nolte, F. & Hofmann, W.-K. et al.​ (2017) 
    Annals of Hematology, 96(6) pp. 887​-894​.​ DOI: https://doi.org/10.1007/s00277-017-2983-0 
    ​Details  DOI 
  • 2017 | Journal Article
    ​ ​Accurate quantification of chromosomal lesions via short tandem repeat analysis using minimal amounts of DNA​
    Jann, J.-C.; Nowak, D.; Nolte, F.; Fey, S.; Nowak, V.; Obländer, J. & Pressler, J. et al.​ (2017) 
    Journal of Medical Genetics, 54(9) pp. 640​-650​.​ DOI: https://doi.org/10.1136/jmedgenet-2017-104528 
    ​Details  DOI 
  • 2016 | Journal Article
    ​ ​Osteolytic lesions occur rarely in patients with B-CLL and may respond well to ibrutinib​
    Shumilov, E.; Wulf, G. ; Ströbel, P. ; Hasenkamp, J. ; Hellige, N.; Bleckmann, A.   & Haase, D.  et al.​ (2016) 
    Leukemia & Lymphoma, 57(10) pp. 2476​-2480​.​ DOI: https://doi.org/10.3109/10428194.2016.1151510 
    ​Details  DOI 
  • 2016 | Journal Article
    ​ ​Frequency and Prognostic Significance of Cytogenetic Abnormalities in 1269 Patients with Therapy-Related Myelodysplastic Syndrome - a Study of the International Working Group (IWG-PM) for Myelodysplastic Syndromes (MDS)​
    Kuendgen, A.; Tuechler, H.; Nomdedeu, M.; Haase, D. ; Garcia-Manero, G.; Komrokji, R. S. & Sole, F. et al.​ (2016) 
    Blood, 128(22) pp. 112​-112​.​ DOI: https://doi.org/10.1182/blood.V128.22.112.112 
    ​Details  DOI 
  • 2016 | Journal Article
    ​ ​Mammalian-target of rapamycin inhibition with temsirolimus in myelodysplastic syndromes (MDS) patients is associated with considerable toxicity: results of the temsirolimus pilot trial by the German MDS Study Group (D-MDS)​
    Wermke, M.; Schuster, C.; Nolte, F.; Al-Ali, H.-K.; Kiewe, P.; Schoenefeldt, C. & Jakob, C. et al.​ (2016) 
    British Journal of Haematology, 175(5) pp. 917​-924​.​ DOI: https://doi.org/10.1111/bjh.14345 
    ​Details  DOI  PMID  PMC  WoS 
  • 2015 | Journal Article | Research Paper | 
    ​ ​Rare cytogenetic abnormalities in myelodysplastic syndromes.​
    Bacher, U. ; Schanz, J. ; Braulke, F.   & Haase, D. ​ (2015) 
    Mediterranean Journal of Hematology and Infectious Diseases, 7(1) art. e2015034​.​ DOI: https://doi.org/10.4084/MJHID.2015.034 
    ​Details  DOI  PMID  PMC 
  • 2009 | Journal Article | 
    ​ ​Standardization of flow cytometry in myelodysplastic syndromes: report from the first European LeukemiaNet working conference on flow cytometry in myelodysplastic syndromes​
    van de Loosdrecht, A. A.; Alhan, C.; Bene, M. C.; Della Porta, M. G.; Drager, A. M.; Feuillard, J. & Font, P. et al.​ (2009) 
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 94(8) pp. 1124​-1134​.​ DOI: https://doi.org/10.3324/haematol.2009.005801 
    ​Details  DOI  PMID  PMC  WoS 

Publication List

All Articles (Book & Journal) Articles & Preprints Papers (Journal & Conference)

Type

Subtype

Date issued

Author

Peer-Reviewed

Organization

Language

Fulltext

Options

Citation Style

GRO View APA Chicago MLA Vancouver
https://publications.goettingen-research-online.de URI: /cris/rp/rp34161
ID: 0000000
PREF: default TOKEN:

0

Sort

Issue Date
ASC DESC
Title
ASC DESC

Embed

JavaScript
Link

Export

Activate Export Mode
Deactivate Export Mode

Select some or all items (max. 800 for CSV/Excel) from the publications list, then choose an export format below.